Building trust and transparency? Challenges of the opt-out system and the secondary use of health data in England
Medical Law International · 2019-06 · 19 (2-3) · 159-181
DOI: 10.1177/0968533219879975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Law International, online erschienen am 13.10.2019. Verfasst von Janos Meszaros und 1 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Gefördert von: Academia Sinica.
Abstract (Originalsprache)
After the failure of the care.data programme, a revised opt-out system has been introduced for British citizens to protect their health data from 2018. However, there are several exemptions from the previous and the revised opt-out systems, some of which are overly broad. For instance, the opt-outs may be completely ignored in the case of ‘anonymised’ data. The data protection terminology in the United Kingdom is slightly different from that in the European Union, and the key issue is that the terms are not used consistently, even in the most important documents and guidelines. This situation may lead to a weak opt-out system with transparency issues, which might erode public trust and lead to a repeat of the care.data failure. Furthermore, the United Kingdom intends to comply with the General Data Protection Regulation after Brexit, thus these differences may cause compatibility issues in the future.
Förderung
- Academia Sinica
Zitieren
APA
Meszaros, J., & Ho, C. (2019). Building trust and transparency? Challenges of the opt-out system and the secondary use of health data in England. Medical Law International, 19(2-3), 159-181. https://doi.org/10.1177/0968533219879975
Vancouver
Meszaros J, Ho C. Building trust and transparency? Challenges of the opt-out system and the secondary use of health data in England. Medical Law International. 2019;19(2-3):159-181. doi:10.1177/0968533219879975
BibTeX
@article{Meszaros2019,
author = {Meszaros, Janos and Ho, Chih-hsing},
title = {Building trust and transparency? Challenges of the opt-out system and the secondary use of health data in England},
journal = {Medical Law International},
year = {2019},
volume = {19},
number = {2-3},
pages = {159--181},
doi = {10.1177/0968533219879975}
}
EUVIMED